Called it ! A must read, page-204

If this looks promising, won't need to wait that long. Definitely keeping an eye open as well as my mind, at the current time I don't need to invest in blue chips, as there are ample opportunities on undervalued stocks on the ASX at the moment, even in the biotech/pharma sphere. For those who got in a lot earlier for sure the risk is a lot lower now that they can sell their initial capital. It's all about risk to reward, this is just isn't one I'm willing to make right now, everyone thought MSB was the next CSL, couple of things don't go their way and bam your valuation is a 1/5th of what it was. GLTA.